Nathaniel J. Myall, MD

Article

Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple Myeloma

Author:: Nathaniel J. Myall, MD

Publish date: June 28, 2022

In patients with multiple myeloma, thrombotic microangiopathy is a rare adverse event associated with proteasome inhibitors, such as bortezomib, ca...